COVI-DROPS: Clinical Trials

3 trials of COVI-DROPS, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated, 1 withdrawn. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Completed 1, Terminated 1, Withdrawn 1

Follow COVI-DROPS: new trials by email Literature Review of COVI-DROPS trials Research Report on COVI-DROPS

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Evaluate a Single Intranasal Dose of STI-2099 (COVI-DROPS™) in Outpatient Adults With COVID-19 (US)
COVI-DROPS, Placebo - Covid19
Phase 2CompletedSorrento Therapeutics, Inc.972021-11-162022-02-03
Randomized Study to Evaluate Intranasal Dose of STI-2099 (COVI-DROPS™) in Outpatient Adults With Mild COVID-19 Infection
COVI-DROPS, Placebo - COVID-19
Phase 2WithdrawnSorrento Therapeutics, Inc.2021-11-012022-02-03
Study to Evaluate a Single Intranasal Dose of STI-2099 (COVI-DROPS™) in Outpatient Adults With COVID-19 (UK)
COVI-DROPS, Placebo - Covid19
Phase 2TerminatedSorrento Therapeutics, Inc.1792021-07-162023-01-30

Conditions studied

COVID-19 (3)

Sponsors

Sorrento Therapeutics, Inc. (3)

Countries

United Kingdom (1)  ·  United States (1)

Top investigators

Mike Royal, MD (3)

Results publications

PMID 34473343